PuraPharm Corporation Limited
PuraPharm Corporation Limited (stock code 1498) has been listed on the Main Board of The Stock Exchange of Hong Kong Limited since 8 July 2015. PuraPharm is a leading Hong Kong-based Chinese medicine company engaged in the research and development, production, marketing and sale of Concentrated Chinese Medicine Granules ("CCMG") products which PuraPharm markets under its brand "Nong's (嚙璀嚙踝蕭嚙踝蕭)". PuraPharm also sells a broad range of general Chinese healthcare products, examples being PuraGold (嚙踝蕭嚙瘤嚙踝蕭) and Oncozac (嚙緩嚙確嚙踝蕭), which are essentially Chinese herbal supplements, on an over-the-counter basis, targeted at end-consumers. PuraPharm is currently the supplier of CCMG products to the Hong Kong Hospital. PuraPharm has also established its own Chinese medicine clinics in Hong Kong under the Nong's (嚙璀嚙踝蕭嚙踝蕭) brand. ENM Group is one of the Pre-IPO investors of PuraPharm and held approximately 4.56% shareholding in PuraPharm after its listing.

Please click here for further information of PuraPharm.